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SP-40,40 is a two-chain serum protein which acts in vitro as a potent inhibitor of the assembly of the membrane attack complex of human 
complement. I  contains I 0 cysteine resid ues, the numbers and locations of which are conserved inseveral mammalian species. Evidence is presented 
that all the cysteine residues are involved in interchain (~--~) disulphide bonds. There are no fr~ cystcine residues. The disulphide bond motif 
estal~lished in this study for SP.40,40 is unique and bears no obvious homology to those complement components whose disulphide bonds have 
been assigned, nor is there any homology apparent between SP-40040 and other multi-chain proteins containing disulphide bonds. 
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1. INTRODUCTION 
The human serum protein, $P-40,40, was shown to 
be a disulphide-bonded heterodimer in which both 
chains are encoded by a single mRNA molecule as a 
single chain precursor which is cleaved post-syntheti- 
cally into the 2 constituent chains [1,2]. The normal 
biological function of SP-40~40 is unknown but it acts 
in vitro to prevent the formation of the membrane 
attack complex (MAC) by binding to C5b-6 or C5b-7 
intermediates, and preventing the insertion event into 
plasma membranes which results in the addition of C8 
and C9 complement components to the membrane 
bound C5b-9 (MAC) complex [3-5]. SP-40,40 also 
occurs in human semen [2] and indeed its rat coun- 
terpart, known as sulphated glycoprotein-2 (SGP-2), 
was initially isolated as the major product of Sertoli 
cells [6,7]. 
Neither SP-40,40 nor SGP-2 exhibit extensive se- 
quence homology to any protein other than ho- 
mologues in other species [8-12]. The presence in SP- 
40,40 and SGP-2 of discrete regions with homology to 
myosin heavy chain ha~ been noted [12]. Marginal levels 
of sequence homology have been noted between SGP-2 
and apolipoprotcin 1 [7], and between SP-40,40 and 
complement components, C7, C8 and C9 [2]; the signif- 
icance of both sequence comparisons i as yet unclear. 
Recent observations in this laboratory [13] and else- 
where [14] have revealed that SP-40,40 exists in human 
blood associated with apolipoprotein A-I in high 
density lipoprotein (HDL) particles and a role in lipid 
traffic between tissues has been suggested. Purified apo- 
lipoprotein A-I and SP-40,40 exhibit measurable spe- 
cific affinity for one another [13], accounting for the 
presence of SP-40,40 in HDL particles. 
The earlier work from this laboratory left 2 major 
aspects of the covalent structure of SP-40040 open to 
further investigation. Firstly, the location of the di- 
sulphide bonds within SP-40,40 could not be inferred on 
the basis of sequence homology to any protein of known 
structure. Secondly, the number and exact location of 
the proteolytic cleavage vents which are responsible for 
separating the ~ and fl polypeptide chains were not 
known. 
In this communication we report the location of the 
disulphide bridges of SP-40,40, confirm the presence of 
carbohydrate (CHO) at all six N-linked CHO addition 
sites, and define the carboxyl-terminus of the mature ,6 
chain within narrow limits. 
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2. MATERIALS AND METHODS 
2.1. Purification of SP.40,40 
Human serum was subjected to immunoaffinity chromatography 
essentially as described [1,2] except hat the monoelonal ntibody- 
Sepharose conjugate, after the passage of human serum, was washed 
with 0.5% (w/v) sodium deoxycholate dissolved in20 mM Tris, pH 8.0 
(HCI), to remove apolipoprot¢in A-I attached to serum SP-40,40 [13]. 
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2.2. Dcrrr~~rinurion of &of groups itt SP40,40 
Frrc thiol groups in proteius were determined using the Ellman 
reaction [I 51, In brief, the protein concentrations of small samples of 
lysozymc and SP-40.40 were determined using the Bio-Rad Protein 
Assay Kit (Product No, SOO-OOOI). Known amounts of both proteins 
were dissolved in U. I M Tris, I .O% sodium do&~yl sulphalc (SDS), 
pH 5.0 (HCl), and cxha~lively reduced hy the addition of di\hio- 
threitol (DTT) to a final concentration of IUU mM, boiling for 2 min 
and then incubating for 1 h al ambient emprature. Acetone (9 vols.) 
was then added to each reaction mixture and protein precipitation 
conducted at -20°C for 1 h Protein pellets were recovered by cen- 
trifugstion and washed 3-times in ice-cold acctonc (9 ~01s.) to remove 
cxccss reducing agent. Samples were then dissolved in 20 ~1 6 M 
guanidine hydrochloride; LOO ~1 of water was added followed by 10 
~01s. of Ellman’s reagent (0.13% (w/v) dithiobis nitrobenzoic acid 
(Sigma) dissolved in 40 mM Na2HPOJ, pH 8.1) to each protein 
sample. 
Known concentrations of both dithiothrcitol and /?-rnercapto- 
ethanol were used to construct he (linear) curve relating A:‘,$ and 
[-SH]. Absorbance measurements were made irnmcdiately after addi- 
tion of Ellman’s reagent. 
Proteins were dialyscd against 1% acetic acid (v/v) and lyophilised. 
Known amounts of sample were digested with cyanogen bromide 
(CNBr) by dissolving aliquots (IOO-500 ,~g protein) in 100 ,uI of 70% 
(v/v)aqucoos formic acid containing CNBr (Pierce, 25 mg/ml). Digc%ts 
were incubated overnight at room tcmpcrature and then rotary cva- 
poratcd to dryness everal times, ndding 200 ,&I ml of Hz? between 
dry-down steps, Samples were dissolved in 6 M guanrdrnc hydro- 
chloride, 100 mM Tris, pH 8.0 (HCI). Tar chromatography, and in 
Lacmmli SDS-lysis bull’cr for SDS-PAGE. 
Digests with trypsin (Worthington), cndoproteinasc glu-C (Boeh- 
ringer-Mannheim) and endoproteinase lysinc-C (Bochringcr- 
Mannhcim) wcrc conducted as previously described [2]. Pepsin diges- 
tions were conducted by dissolving protein in 70% formic ncid at a 
concentration of 50 mg/ml. 20 ~01s. of I rnM HCI containing enzyme 
(I % enzymc:substrate (E:S) ratio) were added for overnight digestions. 
Thermolysin (Boehringcr-Mannheim) digests of SP-40.40 were con- 
ducted in a buffer of 2 mM CaCI:, 100 mM ammonium bicarbonate, 
pH 6.8 (CO,). at a maximum ES ratio of 5:lOO. Digests were rotary 
evapontcd to dryness and dissolved in IOU ~1 volumes of 6 M guan- 
idinc hydrochloride, 100 rnM Tris, pH 8.0 (HCI). Aliquots were then 
either reduced with dithiothreito! (D-IT, IO mM) and treated with 
iodoacctamidc (22 mM) or iodoacctamidc alone without prior reduc- 
tion. Samples were subjcvted to reverse-phase HPLC within 2 h of 
alkylation. 
2.4. Peptirle sepaidon 
Reverse-phase HPLC was conducted using a complete Pharmacia 
FPLC equipped with AT’,,, delection unit. Aectonitrilc gradients were 
used for peptidc elution as indicated. All pcptides to bc scqucnccd were 
purified by 2 rounds of chromatography, one using 20 mM formic 
acid, pH 4.0 (NH,), as a buffer and the second round using 0.1% (v/v) 
trifluoroacctic acid (WA) as a buffer. The matrices used to conduct 
chromatography were Pharmacia Pep-RPC HRS/S (C,C,,) or Pro- 
RPC HR5/10 (C,C,) columns as indicated. 
An Applied Biosystcms (ABI) Model 471A Protein Squencer was 
used to perform the automated Edman degradation on relevant pcp- 
tide samples. The system was quipped with a Brownlcc Laboratories 
microgradient delivery system which was electronically interfaced with 
the Protein Sequencer. The separation of PTH amino acids was con- 
ducted using an ABI PTH column elutcd using 2 buffers, lhc composi- 
tions of which were optimiscd according to the manufacturer’s re- 
commendations [16]. Detection of PTH amino acid peaks was by 
absorbance at 269 nm, All scqucncing reagents used were obtained 
from ABI. 
LG. Grl efecrroplmresis urtd elcclrophoreric frarrsfcr 
Polyacrylamidc gel clcctrophorcsis (PAGE) in the presence of SDS 
was conducted by the mellrod of Lacmmli [Il. Tnnsfcr of proteins 
from slab gels to polyvinyl diiluoridc (PVDF) membranes (Immo- 
bilon, Milliporc) was conducted at 60 V for I-1.S h using 0.1 M 3. 
ojzluhexylamino-l-propane-sulphuric ac d (CAPS, Sigma), pH 1 I 
(NSXij; frltcrs wcrc stained with Coomassic briiliant blue and 
destained with 7% (v/v) aqueous acetic acid. 
3. RESULTS 
3.1. S&40,40 cortlaitts no free rlliol group 
The results of Table 1 reveal that non-reduced SP- 
40,40 contains much less than 1 free -SH group per 
molecule. Material reduced before titration of thiol 
groups yielded values of about 8 mol of thiol group per 
mol of the S&40,40 protein and the corresponding 
value for lysozyme was approximately 9. These values 
concord fairly well with the known values of 10 and 8 
cysteine residues per molecule for SP40,40 and ly- 
sozyme, respectively. Without reduction neither ly- 
sozyme nor SP-40,40 were found to contain significant 
free thiol groups. The experiment with reduced and ex- 
haustively carboxamidomethylated lysozyme rules out 
any contribution from carry over reducing agent 
(DTT). 
3.2. CNBrp~oduces a 4O-kDu frugment of SP-40,40 COII- 
rainitg al/ IO cystrirtc residues 
Gel electrophoresis of a CNBr digest of SP-40,40 
produced a single fragment which was reducible by 
DTT (Fig. 1). The approximate mol. wt. of the CNBr-1 
fragment (40 kDa) suggested that multiple segments of 
the SP-40,40 dimer must be crosslinked by disulphide 
bonds. Fig. 2 depicts the location of methionine, half- 
cysteine and glycosylated asparagine residues in both a 
and p chains of SP-40,40 and assigns mol. wts. to each 
Table I 
Determination of cystcinc and canine residues of SP-40,40 using 
Ellman’s reagent 
Thiol groups per mol of protein 
Prolcin Reduced Non-rcduccd 
SP-40,40 7.9 0.4 
8.2 0.3 
Lysozyme 9.2 0.4 
8.6 0.3 
CAM lysozyme 0.4 0.1 
0.2 0.2 
Duplicate mcasuremcnts of thiol groups arc shown. Protein con- 
ccntradons were determined using the Bio-Rad Protein Assay (Ma- 
terials and Methods). 26Oflg of SP-40.40 (3.25 nmol). 20O~(g of inlacl 
lysozyme and rcduccd and oarboxamidomcthylatcd (CAM) lysozyme 
(13.8 nmol) wcrc used in rclevinnt experiments. Assumed mol. wt. for 
Spa.40 and lysozyme were 80,ooO and 14,400 Da. rcspcctively. 
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Fig. 1. Denaturing polyacrylamide gel electrophoresis of aflinity 
purified intact SP.40,40 (lanes 1,3) and CNBr.cleavcd SP-40,40 (lanes 
2,4). Approximately 3lug of both intact and CNBr-cleaved SP40,40 
were subjected to SDS-PAGE without prior reduction on a 12.5% gel 
(NR, lanes 1 and 2, respectively) while 3 ,ug of intact as well as 
CNBrslenved SP-40,40 were reduced prior to eleclrophoresis on the 
same gel (RED, lanes 3 and 4. respectively). Migration positions for 
standard marker proteins (Pharmacia) and their relative mol. masses 
arc indicated. The gel was stained with Coomassie brilliant blue. 
predicted CNBr fragment [2]. Clearly, if all the half- 
cystine-containing fragments occur in the peptides of 
Fig. 2 (i.e. fragments 82, p3, /?4, a5 and a6), then equi- 
molar amounts of 5 distinct sequences should occur in 
this fragment. Electrophoretic transfer to an Immobilon 
membrane followed by sequence analysis of CNBr-1 
was consistent with the presence of all 5 predicted se- 
quences (Table II). Similarly, addition of the mol. wts. 
of the predicted half-cystine-containing peptides 
produced a value of 40,680 Da (assuming an IV-linked 
carbohydrate chain contributes 3,000 Da); the agree- 
ment between predicted and measured mol. wts. of 
CNBr-1 is well within the experimental limitations of 
SDS-PAGE. 
3.3. Enzyymatic proteoiysis of intact SP-40,40 and 
CNBr-I 
A number of enzymes were used to digest intact SP- 
40,40 or its fragment CNBr-1. After each digest, an 
aliquot of material was reduced and then both reduced 
and non-reduced igest samples were alkylated and sub- 
jected to reverse-phase HPLC. Peptide fragments which 
occurred in the non-reduced but not the reduced igests 
were repurified, and small samples ubjected to reduc- 
tion and alkylation to confirm that they contained at 
least 1 disulphide bond, and finaily the purified non- 
reduced material was subjected directly to sequence 
analysis or further digested with a second cleavage 
reagent prior to re-chromatography and sequence anal- 
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Fig. 2. Schematic and tabular representation f the location of mea 
thionine, half-cysteinc and glycosylatcd asparagine residues of SP- 
40,40. Approximate mol. mass of each peptide was calculated assum- 
ing 120 Da per amino acid and a contribution of 3,000 Da for every 
N-linked carbohydrate moiety. Amino acid residues are numbered 
according to the strict order in which they appear in thep-a precursor 
molecule [2]. 
ysis. The chromatograms of Fig. 3a and b depict this 
analysis using the enzyme trypsin. From this particular 
digest 2 relevant peptides, T-2 and T-21, were recovered 
and their sequences are shown in Table II. Chromato- 
graphy of pepsin-digested peptide T-21 resulted in the 
recovery of a single major fragment TIP-16 (Fig. 4). The 
amino acid sequence of peptide T/P-l6 is shown in 
Table II, which contains sequence data on all the pep- 
tide sequences relevant o this investigation. 
The following points emerged from analysis of the 
data presented in Table II: 
(i) Cysteine residues 80 (@) and 291 (a) are bonded. 
The peptides which evidence this are CNN8-24 and 
CN/P-21. 
(ii) Cysteine residues 107 @) and 263 (a) are bonded 
as indicated by peptide T-2 and CNNS-23. 
(iii) Peptide CN/T-30 contains 2 sequences in similar 
amounts. One sequence corresponds to residues 277- 
286(a) and encompasses cysteine 280 and 283 (a). This 
peptide terminates at 286 and thus cysteine 291 (a) is 
not present, The other sequence corresponds to residues 
U-55 i_@ and contains cyst&e residues 9i slnd 94 Q3j 
but terminates at residue 95 and thus does not contain 
cysteine residue 99 (,Q. Thus cysteine 91 @) is joined to 
either cysteine 280 or 283 (a), and cysteine 94 @?) is 
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Table II 
Amino acid compofition of peptides confirming the lcn:ation of di- 
sulphide bridges, the carboxyl.terminus of the mature #-chain and N- 
linked glycosylation sites of the SP-40,40 molecule 
Cycles where no PTH-amino acid derivative was assigned are indi- 
cated with (-) where the eDNA of SP-40,40 pr~gllets a ¢ystein¢ residue 
or (*) where asparagine is the predicted residue. (~)  Sequence contin- 
ued on the next line. 
p ~.~T'I DE SEOUENCE ,~,~ T T T ON TN 
~lm.4 0. At'l 
e~r,,:-~ fsl f~If-I fol fsl fKl . . . .  ~ z3-:.s 
I~ll~Alwllzllzll-I . . . .  I~ 86-gx 
Ixl lr l lYi lMlallvl . . . .  I~ 101-106 
IDIIrI[HIIzlI~Itsl . . . . .  -','a~-~a2 
tl~J LDJ iQ~ t - J  [DJ LKJ . . . .  a 277-2~2 
r -~  ft.1 fwl f~.l f=l ft'l fal fvl f-1 f-1 fzl f?l fxl . . . .  ~ 7~-a4 
Izt IhllPI [allvil-II-I lml Iwll~ll~,ll~l . . . .  I~ "~s-sm 
Ixl I~Ll~l Io11-1 h~ll~ll-I kaJtzJtzJ tzJ o ~s-2~7 
t~J t,J tsJ t~J taJ t-I ~=) fro ~ ~-~s  
c~/vs-~n f r l  fKl fzl fKl fzl fhlfml fol fvl f - I  f , l  fml ~ ~z-0~ 
,LzJ t~.l tsJ Lv,I l~J l.-J tsJ t'~J twJ t,J h,,I lsJ ~ , r~,z  ,, ~ns-ao4 
ctwt~-2 ~ fs't fsl f=l ftCl . . . .  ~ "7,a-7'~ 
tsJ LvJ ttxl t-J . . . . .  28S-29]. 
~-~ fvl I-11"~1 ~ ~OS-~OS 
iTJLvJ[-~R a 261-264 
cw/vs-zz f~l fzl fzl f;d fal fvl f-I fal fsl GS~.LW-aO~r. ~ ~.o~.-~ z~ 
LGJ LDJ LpJ LDJ ip,,I L~J LvJ LIJ LRJ a 256-265 
c.~/'r-~0 " (m.l r=l (wl (~I [zl f-I f~l fPl-,.~ o o~-gs 
l ld LDJ L~J t-J t~J t~J l- J  fro ,~ zvv-zoa 
~/~-~s fwl fzl fzl f-I ft<l ft, l f-I f=l fzl fol f~l-x.x i~ os-~o~ 
h.~llrd I~IIolI-I lollwll-I taJtz} izJ ,, :'Tm-e~ 
bU i,J tsJ lCJ LoJ L-J L:,J Lrd a 26S-295 
Th/L-53 KRED~L = ETRES ~ SS-~ 
CN~7 QDIIFSRASS Z ~ D~LFQDP~FTR~PQDTYP,~ L-~ 
PFSLPHRRPHFFFP~SR~VR ~ 155"201 
joined to the remaining cysteine residue (a~). Attempts 
to sub-digest peptide CN/T-30 with several enzymes 
were unsuccessful and an unambiguous assignment of 
its disulphide bonds was not possible. 
(iv) Cysteine residues 99 (fl) and 273 (0c) are bonded. 
A disulphide-bonded peptide containing 3 sequences (T/ 
P-16) was isolated. Peptide T/P-16 contained residues 
88-101 (fl) and included cysteine residues 99° 94 and 91 
(fl) and residues 276-286 (~) which includes cysteines 
280 and 283 but not cysteine 291 (g). It also contained 
residues 268 to 275 including eystein¢ 273 (ct). Since 
cysteine residues 94 and 91 (fl) were known to be 
bonded to cysteines 280 and 283 (g), the only way to 
account for the existence of the peptide spanning 
residues 268-275 is to invoke the existence of a di- 
sulphide bond between cysteines 273 (00 and 97 (fl). 
Despite repeated attempts using cleavage reagents of 
differing specificities, no fragments corresponding to a 
disulphide-bonded doublet containing only cysteine 
residues273 (00and 97 (,8) were isolated. The reason(s) 
for this are unclear. 
The locations of the disulphide bonds of SP-40,40 are 
depicted in Fig. 5 along with schematic representations 
m 
B 
, 10m[  
t 
Fig. 3. Isolation ofcystine-containing SP-40A0 peptidcs. Parallel tryp- 
tie digests of(A) non.reduced and (B) reduced and alkylated SP-40.40 
were subjected sequentially to reverse-phase HPLC using a complete 
Pharma¢ia FPLC with a Pep-gPC (C~) HR 5/5 column as the station- 
ary phase. Digests were carried out as described in Materials and 
Methods. Briefly, peptide5 wer~ elated by a l iner  a~tonitril¢ gradient 
composed of buffer A (20 mM formic acid, pH 4 t'NH~)) and buffer 
B ( 15 mM formic acid, pH 4 (NH~), 92.5% acetonitrile) and delivered 
in 3 sesments: (i) 0',% B, 0-5 s in ;  (ii) 0--40% B, 5-55 s in ;  and (iii) 
40-60% B, 55-75 s in  at a constant flow rate of I ml/min throughout 
the gradient. Elation of l~ptid,'s was monitored at a wavelength of 214 
nm. Arrows indicate the presence (in A) or absence (in B) of unique 
non-reduced 5P.40,40 peptides. 
of all the peptides in Table 11 which enabled the estab- 
lishment of the model. 
One peptide which did not conform to the model of 
Fig. 3 was isolated (CN/V8-6). This peptide consisted of 
a single sequence xtending from residue 277-285 (g). 
No sequence assignments were possible at positions cor- 
responding to cysteines 280 and 283 Off) indicating that 
this fragment contained an intrachain disulphide bond. 
The peptide was isolated as a minor peak; its yield was 
low (<1%) as determined by quantification of its PTH 
amino acids after sequencing. If this disulphide bond 
were to exist in native SP-40A0 then the locations of  
essentially all of the other disulphide bonds independ- 
ently assigned in this work would be in error. Indeed the 
existence of peptide CNBr-I (Fig. 1) would be impos- 
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Fig. 4. Pepsin digest ortryptic peptide T-21, Digests were carried out 
as described in Materials and Methods. HPLC was carried out us 
described in the legend to Fig. 3. 
sible without multiple changes to the proposed model, 
It seems much more likely that a low level of disulphide 
interchange may have occurred during the digestion or 
chromatography steps which resulted in the isolation of 
peptide CNNS-6, that is, an experimental rtifact. Such 
events have been reported by other investigators to 
result from the use of high pH buffers such as were used 
in this investigation [18]. 
3.4. The locatiott of the carboxyf tetmbzus of the SP- 
40,40 fl chair2 
Previous investigations did not reveal the precise 
length of the B chain of SP-40,40. At least one proteoly- 
tic cleavage vent must occur in vivo to cleave the bond 
between B Arg-205 and a Ser.1 but additional cleavage 
events may shorten the B chain further. A peptide was 
isolated corresponding in amino-terminal sequence to 
that predicted for CNBr/?7 of Table II. Sub-digestion of 
this fragment with endoproteinase lysine-C followed by 
direct sequence analysis of the unfractionated mixture, 
revealed 2sequences: one, the original amino-terminus, 
the other commencing at serine residue 201 which ex- 
tended through to Ile-203 which is within 2 residues of 
the commencement of the SP-40,40 a chain. The failure 
to detect he remaining 2residues Val-204 and Arg-205 
may be their removal in vivo due to endogenous carbox- 
ypeptidase activity or to the technical problem of se- 
quencing small amounts of peptide material to comple- 
tion. 
3.5. AlI potential N-linked glycosylation sites in SP- 
40,40 ure used 
Asparagine residues within NX; motifs occur at 
residues 64,81, 123,269,332 and 352 [2]. Conventional 
PTM amino acid detection techniques do not allow the 
identification of glycosylated asparagine residues and 
no positive assignment of such residues can be made. If 
the complete amino acid sequence is known, however, 
the absence of an assignable asparagine residue within 
an NX$ motif establishes that the missing residue must 
be glycosylated. Previous work has established that at 
least 4 potential glycosylation sites of SP-40,40, namely 
123, 269, 332 and 352, are actually used [2]. Peptides 
Th/L-53 and CNNS-24 of Table II correspond to se- 
quences flanking asparagine residues 64 and 81. In nei- 
ther case was an assignable PTH-asparagine detected at 
the expected sequencing cycles, indicating that both of 
these potential N-linked glycosylation sites carry carbo- 
hydrate (CHO) chains in SP-40,40. 
4. DISCUSSION 
This work has resulted in the assignment of the di- 
sulphide bonds of SP-40,40 and in the completion of its 
covalent structure other than for that of the N-linked 
CM0 side chains. The structure is conveniently depicted 
as a two-dimensional hairpin in which the a and /? 
chains arc covalently joined by 5 disulphide bonds (Fig. 
5, upper panel). The assignment of half-cystine residues 
91 (cc) to either 280 or 283 (~3) leaves a single degree of 
freedom which could not be eliminated ue to the dif- 
ficulty in obtaining convenient cleavages between cyste- 
ine pairs 91 and 94 and between 280 and 283. Thus the 
2 alternative and experimentally indistinguishable 
models for the disulphide motif of SP-40,40 are com- 
bined in Fig. 5, upper panel. Both of these motifs are 
unusual and no disulphide bonded protein known to the 
authors exhibits substantial similarity to either motif. 
Specifically, members of the Ig superfamily contain 
mainly tandemly linked intrachain disulphide bonds 
with a single inter-chain disulphide connecting H and 
1, chains. The human complement component, Cls, was 
recently shown to contain 13 disulphide bonds, 7 of 
which consist of tandem joints between cysteine residues 
which are ‘next in line’ within the primary structure (l--2 
bonds). The remaining 8 disulphide bonds were 
organised into l-3, 24 motifs interspersed between 
simple l-2 motifs [19]. Similarly, bovine factor X con- 
sists of a mosaic of l-2 and 1-3, 2-4 motifs within the 
light chain, l-2 motifs within the heavy chain and a 
single intcrchain disulphide bond [20]. 
To date no data on the disulphide bonding pattern of 
any terminal complement protein is available. Com- 
ponents C6, C7, C8 and C9 are homologous in amino 
acid sequence 121,223 and all contain multiple cysteine 
residues. We noted previously that sequence homology 
may exist between a cysteine-containing segment of SP- 
40,40 and corresponding segments in several terminal 
complement components. lf this sequence homology is 
significant i may underly a more obvious similarity in 
tertiary structure between terminal complement com- 
ponents and SP-40,40. The demonstration of similar 
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Fig, 5. Complete covalent structure of SP-40,40, Assignment of the disulphide bonds and determination f the carboxyl terminus of the mature 
/~-ehain are summarised schematically, (Upper panel) The covalent structure ol" SP-40,40 showing both possibilities for the disulphide bridges ha5 
been deduced from the peptid¢ isolates depicted in the middle and lower panels. All peptides indicated are listed in Table 1I. ~ represent N-linked 
glyeosylation sites. 
disulphide bond motifs in terminal complement com- 
ponents would support a distant ancestral relationship 
to SP-40,40 which extensive amino acid sequence di- 
vergence has obscured. 
Publication of the complete sequence of SP-40,40 
from human° rat, cow, dog and quail [2,7-9,11] plus 
partial sequence from hamster [10] have allowed a com- 
parison to be made of the alignment of these species 
homologues in the key areas of their cysteine rich 
regions. All cysteine residues are conserved in the ma- 
ture chains of the SP-40,40 homologues where sequence 
data for such a comparison is Jailable. The high degree 
ot" homology and the precise alignment of the cysteine 
residues between all species (including phyiogenetically 
distant quail) must reflect he importance of this struc- 
tural motif in the functional and structural integrity of 
the SP-40,40 molecule. 
Finally, Tsuruta et al. [12] have proposed a specula- 
tive model for the secondary structure of SP-40,40 and 
homologues whereby 4 myosin tail-like arms form a 
cross, the core of which is stabilised by disulphide 
bonds. The location of the disulphide bonds elucidated 
in this study is compatible with this proposal. More 
precise structural studies are required to define the 
salient features of this molecule at the levels of second- 
ary and tertiary structure. 
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